Komori
Share Issuance and Disposal4978ReproCELL IncorporatedMaterials and Chemicals

Notice Regarding Completion of Payment for the Issuance of New Shares and the 20th Stock Acquisition Rights by Third-Party Allotment under the Share and Stock Acquisition Rights Issuance Program Agreement, and Withdrawal of the Shelf Registration

Payment was completed for 2,932,000 fourth-series new shares and 29,320 20th-series stock acquisition rights allocated to CVI Investments, Inc. As a result, the issuance program ended and the related shelf registration was withdrawn.

Worth reading
72In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
2932000
Shares (new shares)
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of new shares and stock acquisition rights through a private placement under the Share and Stock Acquisition Rights Issuance Program Agreement

Who receives how much

New shares 2,932,000 common shares / Potential shares underlying the stock acquisition rights 2,932,000 shares (29,320 rights, each convertible into 100 shares)

CVI Investments, Inc.2,932,000 common shares and 2,932,000 potential shares

The lower thin line represents the existing number of shares to which these shares will be added.

New shares ¥119 per share / Stock Acquisition Rights ¥117 per right
Total issue value

Stock Acquisition Rights ¥3,430,440

Amount of funds to be raised
New shares ¥348,908,000 / Stock Acquisition Rights ¥469,618,440 (assuming all rights are exercised at the initial exercise price)
Terms of the stock acquisition rights
Exercise price
Initial exercise price of ¥159 per share. The exercise price will not be revised, and there is no upper or lower exercise price limit.
Exercise period
From 21 October 2026 to 18 October 2030
Number of Stock Acquisition Rights
Total issuance: 29,320 rights. Unexercised balance: Not disclosed.
Payment date
20 October 2026
Most recent equity financing
Under the offering conducted through the shelf registration, the total issue price of these common shares was ¥1,460,136,000, the total issue price of these stock acquisition rights was ¥14,747,960, and the combined amount of the issue price of these stock acquisition rights and the exercise payment amount was ¥1,961,595,960. Details of the timing and individual types: Not disclosed.
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of new shares and stock acquisition rights through a private placement under the Share and Stock Acquisition Rights Issuance Program Agreement
Number of shares to be issued or disposed ofNew shares 2,932,000 common shares / Potential shares underlying the stock acquisition rights 2,932,000 shares (29,320 rights, each convertible into 100 shares)
Issue price and disposal priceNew shares ¥119 per share / Stock Acquisition Rights ¥117 per right
Total issue valueStock Acquisition Rights ¥3,430,440
Amount of funds to be raisedNew shares ¥348,908,000 / Stock Acquisition Rights ¥469,618,440 (assuming all rights are exercised at the initial exercise price)
Payment date20 October 2026
Intended allotteeName CVI Investments, Inc. / Number of Shares 2,932,000 common shares and 2,932,000 potential shares
Exercise priceInitial exercise price of ¥159 per share. The exercise price will not be revised, and there is no upper or lower exercise price limit.
Exercise periodFrom 21 October 2026 to 18 October 2030
Number of Stock Acquisition RightsTotal issuance: 29,320 rights. Unexercised balance: Not disclosed.
Most recent equity financingUnder the offering conducted through the shelf registration, the total issue price of these common shares was ¥1,460,136,000, the total issue price of these stock acquisition rights was ¥14,747,960, and the combined amount of the issue price of these stock acquisition rights and the exercise payment amount was ¥1,961,595,960. Details of the timing and individual types: Not disclosed.
Items this document does not state (17)
Estimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The payment procedures for the fourth private placement were completed, completing all issuances under the equity program agreement. In addition, the offering planned under the shelf registration ended.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Completion of Payment for the Issuance of New Shares and the 20th Stock Acquisition Rights by Third-Party Allotment under the Share and Stock Acquisition Rights Issuance Program Agreement, and Withdrawal of the Shelf Registration | ReproCELL Incorporated (4978) timely disclosure | Komori